Viewing Study NCT01778803


Ignite Creation Date: 2025-12-24 @ 7:15 PM
Ignite Modification Date: 2025-12-31 @ 9:12 AM
Study NCT ID: NCT01778803
Status: COMPLETED
Last Update Posted: 2017-05-17
First Post: 2013-01-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer
Sponsor: Verastem, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module